Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
Clinical Genetics|March 28, 2023
Hereditary cancer predispositions: Comparison of multigene panel sequencing on fresh-frozen breast/ovarian tumor versus bloodMathias Schwartz, Virginie Moncoutier, Adrien Peytral, et al.
European Journal of Human Genetics : EJHG|May 13, 2026
Follow-up, cancer risk and mortality in Peutz-Jeghers syndrome: Data from the PRED-IdF networkMaxime Rémond, Youenn Drouet, Antoine Dardenne, et al.
European Journal of Human Genetics : EJHG|December 20, 2017
Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancersLisa Golmard, Laurent Castéra, Sophie Krieger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2018
Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 TrialAlice Bernard-Tessier, Emmanuelle Jeannot, David Guenat, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 27, 2023
Features of colorectal adenomas among young patients with Lynch syndrome according to path_MMR: Results from the PRED-IdF registryHadrien Alric, Elise Coffin, Celine Lekhal, et al.
British Journal of Cancer|May 25, 2016
Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resectionWulfran Cacheux, Etienne Rouleau, Adrien Briaux, et al.
Breast (Edinburgh, Scotland)|December 14, 2023
Male breast cancer: No evidence for mosaic BRCA1 promoter methylation involvementMathias Schwartz, Sabrina Ibadioune, Sophie Vacher, et al.
Journal of Medical Genetics|July 4, 2023
MSH3: a confirmed predisposing gene for adenomatous polyposisMarie-Charlotte Villy, Julien Masliah-Planchon, Anne Schnitzler, et al.
BMC Cancer|April 27, 2020
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trialStefano Kim, Bruno Buecher, Thierry André, et al.
JAMA|June 7, 2011
Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndromeValérie Bonadona, Bernard Bonaïti, Sylviane Olschwang, et al.
Pageof 11